Substance P and Human Immunodeficiency Virus Infection: Psychoneuroimmunology. - Wikidata - awgldk - TriplyDB

Substance P and Human Immunodeficiency Virus Infection: Psychoneuroimmunology.

Substance P and Human Immunodeficiency Virus Infection: Psychoneuroimmunology.

http://www.wikidata.org/entity/Q35135953

about

Potential therapeutic targets for neurokinin-1 receptor antagonists Interleukin-1beta upregulates functional expression of neurokinin-1 receptor (NK-1R) via NF-kappaB in astrocytes.Psychoneuroimmunoendocrinology: clinical implications.Detection of bacterial DNA in painful degenerated spinal discs in patients without signs of clinical infection Substance P (SP) enhances CCL5-induced chemotaxis and intracellular signaling in human monocytes, which express the truncated neurokinin-1 receptor (NK1R)Cannabinoids inhibit HIV-1 Gp120-mediated insults in brain microvascular endothelial cells.Neurokinin-1 receptor expression and function in human macrophages and brain: perspective on the role in HIV neuropathogenesis.

P2860

Q28262693-6D39DA59-44C4-4E6C-A149-0AE42EF2A26A Q33593856-AE68D9DF-2241-49CD-8558-54B977F57B9E Q33768232-58F261B1-EBC7-4463-94F0-28A20B5291B4 Q36265457-B3C78C9D-9854-4610-9FB4-2579997C1185 Q37062163-FA6D354C-245B-42F7-A9BE-DDDB9456C564 Q37074777-DFFE04D8-B009-4ED3-8016-8A0685EA1FC7 Q39905758-79B05AC5-0D88-46AA-89CD-4D51B1FD32BF

P2860

Substance P and Human Immunodeficiency Virus Infection: Psychoneuroimmunology.

http://www.wikidata.org/entity/Q35135953

description

2002 nî lūn-bûn

@nan

2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Substance P and Human Immunodeficiency Virus Infection: Psychoneuroimmunology.

@ast

Substance P and Human Immunodeficiency Virus Infection: Psychoneuroimmunology.

@en

type

label

Substance P and Human Immunodeficiency Virus Infection: Psychoneuroimmunology.

@ast

Substance P and Human Immunodeficiency Virus Infection: Psychoneuroimmunology.

@en

prefLabel

Substance P and Human Immunodeficiency Virus Infection: Psychoneuroimmunology.

@ast

Substance P and Human Immunodeficiency Virus Infection: Psychoneuroimmunology.

@en

P1433

Q35135953-E1150CAD-FF21-4AC4-9609-AC9B72C3B6F1

P1476

Q35135953-572C5F6D-C5AA-465A-AE2D-4D43F293D0C6

P2093

Q35135953-5CF71A5F-B329-49D9-99FD-DF4B7BABF934

Q35135953-5DE82E24-B3A0-4357-855C-C4CF306594A6

Q35135953-EBB3D432-03A6-485D-9034-234B1A4A09EE

P2860

Q35135953-10D7DEF7-753E-47BF-94EF-910BAB501EE6

Q35135953-171527C6-23EC-448C-8B7B-C6E49AEE184C

Q35135953-200B0108-37A8-42E7-9BA4-238B5B68A777

Q35135953-228BA3D4-B44D-48BD-812E-48884C8987D0

Q35135953-2CA1AEE1-A2E7-4E1D-9EAC-DCB5C7471BD0

Q35135953-2E18877F-EB3B-4BAC-8720-62691A5945BE

Q35135953-2EA5C13C-27C2-4E70-BB87-66129B95DBB5

Q35135953-2FF32438-9649-411F-9EF9-A3D303734B00

Q35135953-364231E5-854C-4166-9BEC-AA120EA4DB07

Q35135953-3BAC5F11-48D6-42EA-9A27-11454881AAD6

P304

Q35135953-696252EF-46B3-4508-ACAF-FA4FFE737501

P31

Q35135953-3CB4CA60-D1B5-423B-9517-BC2427CF5F8C

P356

Q35135953-8B422F22-6AEF-4779-94C0-17FA238F78BE

P433

Q35135953-340F046B-F88E-4F22-93A1-C8F0B3836816

P478

Q35135953-403B251B-66EF-44B9-AC99-7A433E4BC16C

P577

Q35135953-55A36214-D258-4FFE-9D09-E32FD03F6B1B

P698

Q35135953-2B679DB4-BC71-459F-A37C-DAD5505D142B

P356

S1092852900022483

P1433

C N S Spectrums

P1476

Substance P and Human Immunodeficiency Virus Infection: Psychoneuroimmunology.

@en

P2093

Dwight L Evans

http://www.w3.org/2001/XMLSchema#string

Steven D Douglas

http://www.w3.org/2001/XMLSchema#string

Wen-Zhe Ho

http://www.w3.org/2001/XMLSchema#string

P2860

The human CD46 molecule is a receptor for measles virus (Edmonston strain)

Altered nociception, analgesia and aggression in mice lacking the receptor for substance P

The primary structure and gene organization of human substance P and neuromedin K receptors

Distinct mechanism for antidepressant activity by blockade of central substance P receptors

Substance P antagonist (CP-96,345) inhibits HIV-1 replication in human mononuclear phagocytes

Respiratory syncytial virus infection and G and/or SH protein expression contribute to substance P, which mediates inflammation and enhanced pulmonary disease in BALB/c mice.

Impaired response to HAART in HIV-infected individuals with high autonomic nervous system activity.

Elevated substance P levels in HIV-infected men.

Neurokinin(1) receptor antagonists as potential antidepressants.

P304

867-874

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1017/S1092852900022483

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2002-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12766696

http://www.w3.org/2001/XMLSchema#string